BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
45.34
-0.67 (-1.46%)
At close: Feb 13, 2026

SHA:688166 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
606.22765.35998.051,180336.84339.53
Trading Asset Securities
--50.6250.120.76180.04
Cash & Short-Term Investments
606.22765.351,0491,230337.6519.58
Cash Growth
19.96%-27.02%-14.78%264.48%-35.02%-27.33%
Accounts Receivable
334.1339.5308.88307.47373.85177.27
Other Receivables
5.196.6619.9118.783.750.92
Receivables
339.3346.17328.79326.25377.59178.19
Inventory
369.39364.61344.63280.35200.06203.2
Prepaid Expenses
--3.655.834.485.76
Other Current Assets
151.69164.1411495.3973.2739.64
Total Current Assets
1,4671,6401,8401,938993.01946.36
Property, Plant & Equipment
2,7382,7052,4892,0761,378452.5
Long-Term Investments
321.12437.06425.86399.33348.28156.88
Goodwill
3.123.127.57.57.5-
Other Intangible Assets
86.589.4893.6681.6480.8448.76
Long-Term Accounts Receivable
4.12.1----
Long-Term Deferred Tax Assets
80.7973.5542.2823.9419.8618.16
Long-Term Deferred Charges
306.5757.4930.1826.8725.8333
Other Long-Term Assets
353.01156.03104.09107.73115.86172.11
Total Assets
5,3605,1645,0324,6612,9701,828
Accounts Payable
188.97266228.18252.19211.8979.63
Accrued Expenses
39.5975.572.3169.0461.7237.47
Short-Term Debt
149.27115.26156.87124.38257.05140.02
Current Portion of Long-Term Debt
725.46516.96397.93313.8716.582.56
Current Portion of Leases
-13.6916.11.349.87-
Current Income Taxes Payable
8.216.6814.0414.973.695.44
Current Unearned Revenue
45.228.022429.4920.3324.82
Other Current Liabilities
10.3620.2712.816.261.931.78
Total Current Liabilities
1,1671,052922.25811.52583.07291.71
Long-Term Debt
1,4591,5801,6151,576618.6977.52
Long-Term Leases
7.310.2121.016.010.22-
Long-Term Unearned Revenue
69.274.7126.25262626
Other Long-Term Liabilities
126.021029.82---
Total Liabilities
2,8282,7272,6142,4201,228395.23
Common Stock
423.1422.47422.47422.47410410
Additional Paid-In Capital
1,036982.361,0571,008738.94701.01
Retained Earnings
1,0621,046897.66743.35555.05345.54
Treasury Stock
-10.01-10.01----
Comprehensive Income & Other
-63.46-46.48-8.6417.77-25.8-24.78
Total Common Equity
2,4482,3952,3692,1921,6781,432
Minority Interest
83.6842.7348.9750.0463.450.78
Shareholders' Equity
2,5322,4372,4182,2421,7421,433
Total Liabilities & Equity
5,3605,1645,0324,6612,9701,828
Total Debt
2,3412,2362,2072,022902.42220.1
Net Cash (Debt)
-1,735-1,470-1,158-791.15-564.82299.48
Net Cash Growth
------58.11%
Net Cash Per Share
-4.15-3.50-2.75-1.91-1.390.72
Filing Date Shares Outstanding
399.34422.11422.1422.47410410
Total Common Shares Outstanding
399.34422.11422.47422.47410410
Working Capital
299.55587.89917.491,127409.94654.65
Book Value Per Share
6.135.675.615.194.093.49
Tangible Book Value
2,3582,3022,2672,1031,5901,383
Tangible Book Value Per Share
5.915.455.374.983.883.37
Buildings
-728.65261.26273.4104.72104.72
Machinery
-1,122704.8318.41287.37253.45
Construction In Progress
-1,1671,7361,6661,131219.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.